{"podcast":{"title":"Lung Cancer Update","slug":"lung-cancer-update-827388","podcast_index_feed_id":827388,"rss_url":"https://feeds.captivate.fm/lung-cancer-update/","website_url":"https://www.researchtopractice.com/browse-tumor-types/lung-cancer","image_url":"https://artwork.captivate.fm/230421a8-7e2e-4fb0-b40c-3b50a1cbf78f/nstTehQJgx-Rm0qFgD_28hl9.png","author":"Dr. Neil Love","episode_count":56,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.","last_synced_at":"2026-07-15T06:20:06.840223+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388"},"episode":{"title":"Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates","slug":"lung-cancer-5-minute-journal-club-issue-4-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates","published_at":"2025-11-10T18:00:00+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388/lung-cancer-5-minute-journal-club-issue-4-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates","show_page_url":"https://stenobird.com/podcast/lung-cancer-update-827388","url":"https://lung-cancer-update.captivate.fm/episode/5553-5mjc2025-trop2lung-4","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/57d5c575-32d1-4e2e-ab7d-f4468f73cffa.mp3","summary":"Dr&nbsp;Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed&nbsp;antibody-drug&nbsp;conjugates in the management of non-small cell lung cancer.&nbsp; CME information and select publications here .","meta_description":"Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1281,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/lung-cancer-5-minute-journal-club-issue-4-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-update-827388/lung-cancer-5-minute-journal-club-issue-4-with-dr-aaron-lisberg-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}